Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: 3Sbio, Amarin, Ampio, Astrazeneca, Beigene, Bellerophon, Biolinerx, Biontech, Bioshin, Boehringer Ingelheim, CASI, Clear Creek, Cytodyn, Edding, Eisai, Gannex, Gemvax & Kael, Helixmith, Idorsia, Immutep, Imugene, Innovent, Kangpu, Kazia, Marinomed, Merck, Molecular Partners, Mydecine Innovations, Organicell Regenerative Medicine, Pfizer, Redhill, Sagimet, Selecta, Trippbio.